Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.30 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
| ▸ | DGKA | P23743 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15944889 | 0.91 | L3MBTL1 (0.35) | MAPTLMNAL3MBTL1 | |
| SCHEMBL15944887 | 0.87 | LMNA (0.35) | MAPTLMNAL3MBTL1MAPK1DGKA | |
| SCHEMBL15944892 | 0.84 | CYP3A4 (0.36) | MAPTLMNAL3MBTL1KDM4EDUSP3 | |
| SCHEMBL722869 | 0.84 | LMNA (0.46) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL720859 | 0.82 | MEN1 (0.43) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL723053 | 0.82 | MEN1 (0.43) | MAPTLMNAKDM4EDUSP3MEN1 | |
| SCHEMBL721966 | 0.81 | LMNA (0.38) | MAPTLMNAL3MBTL1KDM4EDUSP3 | |
| SCHEMBL14616422 | 0.81 | MEN1 (0.36) | MAPTLMNAL3MBTL1KDM4EDUSP3 | |
| SCHEMBL15944886 | 0.81 | MAPT (0.36) | MAPTLMNAL3MBTL1KDM4EDUSP3 | |
| SCHEMBL720697 | 0.80 | MEN1 (0.42) | MAPTLMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10017720-B2 | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents | ECOLAB USA INC. (US) | 2018-07-10 | — | — | US | disclosed |
| US-20170247644-A1 | SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS | ECOLAB USA INC. | 2017-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10017720-B2 | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents | GPX4, PRDX1, PRDX4 | MAPT 4882/4885LMNA 3708/4885L3MBTL1 4721/4885 |
| US-20170247644-A1 | SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS | GPX4, PRDX1, PRDX4 | MAPT 4882/4885LMNA 3708/4885L3MBTL1 4721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.